NeuroPath

NeuroPath’s platform captures data and detects events from the daily living activities of patients with neurodegenerative diseases by using state-of-the-art technologies in motion capturing, Quality of Life surveys, wearables and voice detection.

Using AI, data is analyzed and transformed into objective parameters of disease progression to create insights into care path adherence, treatment results, drug efficacy and personalized care that can be shared with all stakeholders.

Due to its hardware agnostic approach, NeuroPath can develop algorithms by plugging in different sensors and data sets. This can also entail the incorporation of Internet of Thing (IoT) and invisible Patient Reported Outcomes (iPROs). A graphic user interface facilitates the consultation of the reports as well as the custom analytics of the results.

“I see my neurologist every six months for a thirty-minute session. That leaves 8,765 hours per year when my disease is not being monitored.” Parkinson’s disease is very complex, and the progression of the disease is highly individual. Therefore, the need for a constant visibility on the disease progression and the impact of the treatment regimen is crucial to the quality of life of the patient.

NeuroPath supports caregivers and clinicians in personalizing care pathways by engaging patients, significant others and the full ecosystem of clinicians around the patient. Eventually, big data will benefit pharma, CRO and payers.